Intern - Corporate Affairs & Legal - US Legal Business Partner at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • Must be at least 18 years old
  • Must have a minimum GPA of 2.8
  • Authorized to work in the United States without sponsorship now or in the future or CPT/OPT through your University
  • Must be currently enrolled as a full-time student in a JD program at an accredited US-based university or college, and be a rising second-year law student (2L) in Summer 2026
  • Must be enrolled full-time in the Fall Semester at an accredited law school after the completion of the internship
  • Must be able to complete a 10-12 consecutive week internship between May and August
  • Must be able to relocate if necessary and work at the designated site for the duration of the internship

Responsibilities

  • Support the US Legal Business Partners group within Gilead's Legal Department, with a primary focus on the company's flagship US HIV Commercial business
  • Assist other groups within Legal and Ethics & Compliance on a variety of projects across subject matters
  • Work with in-house attorneys to support and provide practical, substantive legal and strategic advice to the business on healthcare legal and regulatory risks related to commercialization of Gilead's HIV drugs and launch of new products
  • Conduct research and analysis of legal and regulatory issues; create presentations, draft memos, and provide recommendations on specific legal and strategic issues relevant to the business
  • Attend meetings with clients and outside counsel, and provide legal support under the supervision of Gilead Legal team members
  • Draft, review, and negotiate contracts
  • Collaborate with stakeholders throughout the legal organization and the business
  • Showcase your work with a final presentation (PPT) near the conclusion of your internship

Skills

Legal Support
Corporate Affairs
Business Partnering
Ethics & Compliance
HIV Commercial
Project Assistance

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI